• 2024 Policy Preview: An Interview with Dr. Mark McClellan

  • Jan 30 2024
  • Length: 50 mins
  • Podcast

2024 Policy Preview: An Interview with Dr. Mark McClellan  By  cover art

2024 Policy Preview: An Interview with Dr. Mark McClellan

  • Summary

  • Scott and Mark welcome Dr. Mark McClellan, a distinguished health policy expert who has served as the Commissioner of the FDA and the Administrator of CMS, to look ahead at the major policy activities in 2024. They discuss how the government's role as regulator and purchaser of drugs will influence the drug industry and the patient's ability to access and afford medicines this year. They also discuss the challenges and opportunities for improving public health and the emerging role of artificial intelligence.

    Dr. Mark McClellan, PhD, Director and Professor of Business, Medicine and Policy at the Duke-Margolis Center for Health Policy at Duke University

    IRA

    Medicare Part D

    Pharmacy Benefit Managers (PBMs)

    Medicare Advantage

    FDA commissioner Rob Califf

    The Ryan White HIV/AIDS Program (RWHAP) Part B

    Medicare Modernization Act

    FDA

    FDA's Office of Regulatory Affairs

    Centers for Medicare & Medicaid Services (CMS)

    Centers for Disease Control and Prevention (CDC)

    Per Member Per Month (PMPM) billing

    Questions or comments?
    Email us at comments@prescriptionforbetteraccess.com.
    Find us on social media! Follow us on X, LinkedIn, YouTube and Threads.



    Show more Show less
activate_primeday_promo_in_buybox_DT

What listeners say about 2024 Policy Preview: An Interview with Dr. Mark McClellan

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.